Hereditary Hemolytic Anemia Panel (For RBC Membrane Disorders and Enzymopathies)

The Hereditary Hemolytic Anemia Panel (for RBC membrane disorders and Enzymopathies) is a powerful diagnostic tool that utilizes Next-Generation Sequencing (NGS) technology to identify genetic variations associated with hereditary hemolytic anemia. This panel specifically targets mutations in genes responsible for red blood cell (RBC) membrane disorders and enzymopathies, which are common causes of hemolytic anemia.

By analyzing multiple genes simultaneously, NGS enables comprehensive and efficient screening for a wide range of genetic variants. The panel identifies mutations in genes such as SPTB, SPTA1, ANK1, EPB42, G6PD, PKLR, and others, which are implicated in various forms of hereditary hemolytic anemia.

NGS-based testing offers high sensitivity and specificity, allowing for accurate identification of pathogenic variants. This information aids clinicians in making precise diagnoses, enabling appropriate management and counseling for patients and their families. The Hereditary Hemolytic Anemia Panel by NGS represents a significant advancement in the field of molecular diagnostics, providing invaluable insights into the genetic basis of these complex disorders.

Note: Genetic counseling can be provided. If interested, please send the request to this email id:[email protected]